fluoxetine has been researched along with Amentia in 19 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of a possible interaction with pimozide which led to a potentially life threatening bradycardia." | 7.68 | Possible interaction between fluoxetine and pimozide causing sinus bradycardia. ( Ahmed, I; Dagincourt, PG; Miller, LG; Shader, RI, 1993) |
| " TRAZODONE: Studies conducted in patients with Alzheimer's disease, mixed type dementia, or fronto-temporal dementia have shown the efficacy of trazodone for diverse types of symptoms: sadness, emotional disorders, irritability, fear, psychomotor instability, delirant ideas." | 4.82 | [Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias]. ( Lebert, F, 2003) |
| " We report a case of a possible interaction with pimozide which led to a potentially life threatening bradycardia." | 3.68 | Possible interaction between fluoxetine and pimozide causing sinus bradycardia. ( Ahmed, I; Dagincourt, PG; Miller, LG; Shader, RI, 1993) |
| "Fluoxetine appears to be an effective and well-tolerated antidepressant in elderly inpatients of varying age, levels of depression, and psychiatric diagnoses." | 2.68 | The use and tolerability of fluoxetine in geropsychiatric inpatients. ( Kunik, ME; Molinari, V; Orengo, CA; Workman, RH, 1996) |
| "Depression is a highly prevalent concomitant of dementia." | 2.40 | Depression and dementia: comorbidities, identification, and treatment. ( Meyers, BS, 1998) |
| "The pattern of myoclonus is unlike previous reported cases and may relate to activation of serotonin 5HT1A receptors (possibly supersensitive in Pick's disease) or to hypodopaminergia." | 1.29 | Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease. ( Lauterbach, EC, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 13 (68.42) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 1 (5.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kostić, V | 1 |
| Dzoljić, E | 1 |
| Todorović, Z | 1 |
| Mijajlović, M | 1 |
| Svetel, M | 1 |
| Stefanova, E | 1 |
| Dragasević, N | 1 |
| Petrović, I | 1 |
| Milosević, M | 1 |
| Kovacević, I | 1 |
| Miljković, B | 1 |
| Pokrajac, M | 1 |
| Prostran, M | 1 |
| Harper, A | 1 |
| Lebert, F | 1 |
| Le Ber, I | 1 |
| Dubois, B | 1 |
| Preskorn, SH | 1 |
| Anderson, IM | 1 |
| Scott, K | 1 |
| Harborne, G | 1 |
| Friedman, EH | 1 |
| Lauterbach, EC | 2 |
| Ahmed, I | 1 |
| Dagincourt, PG | 1 |
| Miller, LG | 1 |
| Shader, RI | 1 |
| Orengo, CA | 1 |
| Kunik, ME | 1 |
| Molinari, V | 1 |
| Workman, RH | 1 |
| Omar, SJ | 1 |
| Robinson, D | 1 |
| Davies, HD | 1 |
| Miller, TP | 1 |
| Tinklenberg, JR | 1 |
| Flint, AJ | 1 |
| Rifat, SL | 1 |
| Auer, SR | 1 |
| Monteiro, IM | 1 |
| Reisberg, B | 1 |
| Swartz, JR | 1 |
| Miller, BL | 1 |
| Lesser, IM | 1 |
| Darby, AL | 1 |
| Anderson, J | 1 |
| Compton, SA | 1 |
| Strachan, J | 1 |
| Shepherd, J | 1 |
| Meyers, BS | 1 |
| Schweri, MM | 1 |
| Sobin, P | 1 |
| Schneider, L | 1 |
| McDermott, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Controlled, Randomized, Double-Blind Trial of Sertraline in Patients With Frontal Lobe Dementia (FLD)[NCT00001777] | Phase 1 | 30 participants | Interventional | 1997-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluoxetine and Amentia
| Article | Year |
|---|---|
[Serotonin reuptake inhibitors in depression of Alzheimer's disease and other dementias].
Topics: Aged; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Clinical Tri | 2003 |
[Frontotemporal dementia].
Topics: Adenosine Triphosphatases; Aged; Aged, 80 and over; Alzheimer Disease; Amyotrophic Lateral Sclerosis | 2007 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cog | 1998 |
4 trials available for fluoxetine and Amentia
| Article | Year |
|---|---|
Fluoxetine does not impair motor function in patients with Parkinson's disease: correlation between mood and motor functions with plasma concentrations of fluoxetine/norfluoxetine.
Topics: Activities of Daily Living; Affect; Antidepressive Agents, Second-Generation; Dementia; Depression; | 2012 |
The use and tolerability of fluoxetine in geropsychiatric inpatients.
Topics: Age Factors; Aged; Antipsychotic Agents; Dementia; Depressive Disorder; Drug Therapy, Combination; F | 1996 |
Behavioral symptoms in dementia: community-based research.
Topics: Aged; Alzheimer Disease; Ambulatory Care; Antipsychotic Agents; Dementia; Double-Blind Method; Femal | 1996 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Fron | 1997 |
12 other studies available for fluoxetine and Amentia
| Article | Year |
|---|---|
What is best for the patient?
Topics: Aged; Anxiety Disorders; Cardiovascular Diseases; Dementia; Evidence-Based Medicine; Fluoxetine; Ger | 2003 |
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin; | 2008 |
Serotonin and depression in frontal lobe dementia.
Topics: Adult; Combined Modality Therapy; Dementia; Depressive Disorder; Drug Therapy, Combination; Electroc | 1995 |
Re: Bradycardia and somnolence after adding fluoxetine to pimozide regimen.
Topics: Aged; Bradycardia; Brain Stem; Cerebral Cortex; Dementia; Dominance, Cerebral; Drug Synergism; Fluox | 1994 |
Reversible intermittent rhythmic myoclonus with fluoxetine in presumed Pick's disease.
Topics: Affective Disorders, Psychotic; Brain; Dementia; Dose-Response Relationship, Drug; Electroencephalog | 1994 |
Possible interaction between fluoxetine and pimozide causing sinus bradycardia.
Topics: Aged; Arrhythmia, Sinus; Bradycardia; Delusions; Dementia; Depressive Disorder; Dose-Response Relati | 1993 |
Fluoxetine and visual hallucinations in dementia.
Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Dementia; Depressive Disorder; Dr | 1995 |
The effect of sequential antidepressant treatment on geriatric depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Clinical Protocols; Combined Modality Therapy; Demen | 1996 |
Fluoxetine induced bradycardia in presenile dementia.
Topics: Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Bradycardia; Dementia; Fluoxetine | 1997 |
Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Dementia; Depressive Disorder; Dr | 1998 |
Amelioration of pseudobulbar affect by fluoxetine: possible alteration of dopamine-related pathophysiology by a selective serotonin reuptake inhibitor.
Topics: Affect; Caudate Nucleus; Dementia; Fluoxetine; Humans; Male; Middle Aged; Neurocognitive Disorders; | 1991 |
Fluoxetine in the treatment of agitated dementia.
Topics: Aggression; Dementia; Fluoxetine; Humans; Male; Middle Aged; Psychomotor Agitation | 1989 |